Abstract
The 7th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting, organized in conjunction with the 45th Annual Congress of the Société Internationale d’Urologie, was held on 31 October 2025, in Edinburgh, Scotland, and transmitted live on the SIU@U Congress app
Keywords
Funding Information
  • Daiichi Sankyo | AstraZeneca
  • Johnson and Johnson
  • Bristol Myers Squibb
  • CG Oncology
  • Ferring Pharmaceuticals
  • Merck Sharp & Dohme
  • Novartis Pharma AG

This publication has 67 references indexed in Scilit: